TrustCore Financial Services’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$738 Hold
21
﹤0.01% 954
2022
Q3
$1K Sell
21
-102
-83% -$3.87K ﹤0.01% 1000
2022
Q2
$7K Buy
123
+101
+459% +$5.58K ﹤0.01% 796
2022
Q1
$1K Hold
22
﹤0.01% 992
2021
Q4
$1K Hold
22
﹤0.01% 909
2021
Q3
$1K Hold
22
﹤0.01% 983
2021
Q2
$1K Sell
22
-800
-97% -$38.4K ﹤0.01% 1013
2021
Q1
$37K Sell
822
-239
-23% -$10.8K ﹤0.01% 493
2020
Q4
$49K Buy
1,061
+1,039
+4,723% +$47.7K 0.01% 429
2020
Q3
$1K Hold
22
﹤0.01% 801
2020
Q2
$1K Sell
22
-265
-92% -$13.6K ﹤0.01% 840
2020
Q1
$14K Hold
287
﹤0.01% 533
2019
Q4
$17K Sell
287
-866
-75% -$48.2K ﹤0.01% 546
2019
Q3
$62K Buy
1,153
+10
+0.9% +$514 0.01% 335
2019
Q2
$57K Buy
1,143
+13
+1% +$652 0.01% 339
2019
Q1
$59K Buy
1,130
+9
+0.8% +$450 0.02% 282
2018
Q4
$54K Sell
1,121
-457
-29% -$22.5K 0.03% 144
2018
Q3
$79K Sell
1,578
-40
-2% -$2.03K 0.02% 254
2018
Q2
$81K Buy
1,618
+76
+5% +$3.83K 0.03% 231
2018
Q1
$75K Buy
1,542
+805
+109% +$37.5K 0.03% 232
2017
Q4
$33K Buy
+737
New +$34K 0.01% 327

Other funds holding GSK

TrustCore Financial Services's GSK Position: Q4 2022 in Review

TrustCore Financial Services held its GSK (GSK) position steady in Q4 2022 at 21 shares worth $738. The position accounts for ﹤0.01% of the portfolio, ranked #954.

TrustCore Financial Services first reported a position in GSK in Q4 2017 and has held it in 21 quarters since. The position peaked at $81K in Q2 2018. 813 funds tracked by Wall St. Rank hold GSK as of Q4 2022.

  • TrustCore Financial Services held 21 shares of GSK worth $738 as of Q4 2022.
  • TrustCore Financial Services left its GSK share count unchanged in Q4 2022.
  • GSK made up ﹤0.01% of TrustCore Financial Services's portfolio in Q4 2022, its #954 holding.
  • TrustCore Financial Services first reported a position in GSK in Q4 2017 and has held it in 21 quarters since.
  • TrustCore Financial Services's GSK position peaked at $81K in Q2 2018.
  • 813 funds tracked by Wall St. Rank held GSK as of Q4 2022.

Based on TrustCore Financial Services's 13F filing for Q4 2022, filed 13 Feb 2023.